Ceapro (CVE:CZO) Trading Down 11.8% – What’s Next?

Ceapro Inc. (CVE:CZO) fell 11.8% during trading on Thursday . The company traded as low as C$0.23 and last traded at C$0.23. 5,850 shares were traded during mid-day trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.

Ceapro Trading Down 11.8 %

The company has a quick ratio of 18.88, a current ratio of 8.54 and a debt-to-equity ratio of 8.07. The company has a market cap of C$17.62 million, a price-to-earnings ratio of -3.75 and a beta of 1.38. The firm has a 50 day moving average price of C$0.22 and a two-hundred day moving average price of C$0.23.

Ceapro Company Profile

Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.